| Date | Time | Source | Headline | Symbol | Company |
| 10/16/2017 | 2:00AM | UK Regulatory | MaxCyte, Inc. Declaration of Audit Remuneration | LSE:MXCT | Maxcyte Inc |
| 10/05/2017 | 1:36PM | Alliance News |  Bost-Jackson And Wendell M Starke Build Stakes In Maxcyte (ALLISS) | LSE:MXCT | Maxcyte Inc |
| 10/05/2017 | 1:32PM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 10/05/2017 | 1:31PM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 09/28/2017 | 12:15PM | UK Regulatory | MaxCyte, Inc. Notice of AGM | LSE:MXCT | Maxcyte Inc |
| 09/19/2017 | 7:17AM | Alliance News | MaxCyte Upbeat Despite Widened First Half Loss Due To Increased Costs | LSE:MXCT | Maxcyte Inc |
| 09/19/2017 | 2:00AM | UK Regulatory | MaxCyte, Inc. Interim Results | LSE:MXCT | Maxcyte Inc |
| 08/25/2017 | 2:00AM | UK Regulatory | MaxCyte, Inc. Notice of Half Year Results | LSE:MXCT | Maxcyte Inc |
| 07/20/2017 | 1:02PM | UK Regulatory | MaxCyte, Inc. Grant of Options | LSE:MXCT | Maxcyte Inc |
| 07/12/2017 | 6:28AM | Alliance News | MaxCyte Interim Revenue Rises, On Track To Submit Drug Application | LSE:MXCT | Maxcyte Inc |
| 07/12/2017 | 2:00AM | UK Regulatory | MaxCyte, Inc. Trading Update | LSE:MXCT | Maxcyte Inc |
| 06/06/2017 | 6:08AM | Alliance News | MaxCyte Agrees Collaboration Deal With NIAID For Rare Genetic Disorder | LSE:MXCT | Maxcyte Inc |
| 06/06/2017 | 2:01AM | UK Regulatory | MaxCyte, Inc. Research & Development Agreement with NIAID | LSE:MXCT | Maxcyte Inc |
| 05/31/2017 | 11:30AM | UK Regulatory | MaxCyte, Inc. Total Voting Rights | LSE:MXCT | Maxcyte Inc |
| 05/02/2017 | 8:42AM | UK Regulatory | MaxCyte, Inc. Block Listing Application | LSE:MXCT | Maxcyte Inc |
| 04/25/2017 | 1:27PM | UK Regulatory | MaxCyte, Inc. Holding(s) in Company | LSE:MXCT | Maxcyte Inc |
| 04/25/2017 | 7:23AM | Alliance News | MaxCyte To Report Positive Preclinical Data At Washington Meeting | LSE:MXCT | Maxcyte Inc |
| 04/25/2017 | 2:01AM | RNS Non-Regulatory | MaxCyte, Inc. Presentation of Positive Preclinical Data | LSE:MXCT | Maxcyte Inc |
| 04/20/2017 | 1:00PM | UK Regulatory | MaxCyte, Inc. Result of Special Meeting and Issue of Equity | LSE:MXCT | Maxcyte Inc |
| 04/13/2017 | 8:00AM | UK Regulatory | MaxCyte, Inc. Notice of AGM and 2016 Annual Report and Accounts | LSE:MXCT | Maxcyte Inc |
| 03/31/2017 | 7:57AM | Alliance News | UPDATE: MaxCyte Raises GBP20 Million, Placing 17% Stake At Premium (ALLISS) | LSE:MXCT | Maxcyte Inc |
| 03/31/2017 | 7:40AM | UK Regulatory | MaxCyte, Inc. Results of Placing | LSE:MXCT | Maxcyte Inc |
| 03/31/2017 | 5:49AM | Alliance News | MaxCyte Plans Placing Up To 17% Stake To Raise GBP20 Million (ALLISS) | LSE:MXCT | Maxcyte Inc |
| 03/31/2017 | 2:01AM | UK Regulatory | MaxCyte, Inc. Proposed Placing to raise up to approx. £20.0m | LSE:MXCT | Maxcyte Inc |
| 03/20/2017 | 7:46AM | Alliance News | MaxCyte Confident For 2017 Growth As 2016 Loss Widens | LSE:MXCT | Maxcyte Inc |
| 03/20/2017 | 3:01AM | UK Regulatory | MaxCyte, Inc. Full Year Results | LSE:MXCT | Maxcyte Inc |
| 03/14/2017 | 7:15AM | Alliance News | MaxCyte Inks License Deal With CRISPR Therapeutics And Bayer | LSE:MXCT | Maxcyte Inc |
| 03/14/2017 | 3:01AM | UK Regulatory | MaxCyte, Inc. CRISPR THERAPEUTICS/CASEBIA COMMERCIAL LICENSE | LSE:MXCT | Maxcyte Inc |
| 03/02/2017 | 8:13AM | Alliance News | MaxCyte To Present Pre-Clinical CARMA Data At Conference | LSE:MXCT | Maxcyte Inc |
| 03/02/2017 | 2:01AM | UK Regulatory | MaxCyte, Inc. MaxCyte to Present Pre-Clinical CARMA Data at AACR | LSE:MXCT | Maxcyte Inc |